益气养阴清热解毒汤联合顺铂灌注治疗气阴两虚型肺癌恶性胸腔积液对患者免疫功能、炎症反应及肺纤维化的影响OA
目的 探讨益气养阴清热解毒汤联合顺铂灌注治疗气阴两虚型肺癌恶性胸腔积液(MPE)对患者免疫功能、炎症反应及肺纤维化的影响.方法 选取2020年1月至2025年2月该院收治的80例MPE患者作为研究对象,按治疗方法不同均分为对照组(给予胸腔穿刺引流后顺铂灌注治疗)和观察组(在对照组基础上给予益气养阴清热解毒汤治疗),各40例.比较2组肺纤维化、不良反应发生情况及治疗前后免疫功能指标[CD3+、CD4+、CD8 T细胞比例及CD4+/CD8+比值)]、血清炎症因子[C-反应蛋白(CRP)、白细胞介素-6(IL-6)、血清肿瘤坏死因子-α(TNF-α)]水平、肺功能指标[用力肺活量(FVC)、第1秒用力肺活量(FEV1)、最大呼吸流速(PEF)]、中医证候积分.结果 治疗3周后,2组CD3+T细胞、CD4+T细胞比例及CD4+/CD8+比值高于治疗前,且观察组CD3+T细胞、CD4+T细胞比例及CD4+/CD8+比值高于对照组,差异均有统计学意义(P<0.05).治疗3周后,2组血清CRP、IL-6、TNF-α水平及CD8+T细胞比例低于治疗前,且观察组血清CRP、IL-6、TNF-α水平及CD8+T细胞比例低于对照组,差异均有统计学意义(P<0.05).治疗3周后,2组FVC、FEV1、PEF高于治疗前,且观察组FVC、FEV1、PEF高于对照组,差异均有统计学意义(P<0.05).治疗3周后,2组咳嗽痰少、咳声低弱、神疲乏力、潮热盗汗、头晕眼花、面色少华积分及总积分低于治疗前,且观察组咳嗽痰少、咳声低弱、神疲乏力、潮热盗汗、头晕眼花、面色少华积分及总积分低于对照组,差异均有统计学意义(P<0.05).治疗3周后,2组患者肺纤维化分级比较,差异有统计学意义(P<0.05).治疗期间观察组骨髓抑制、恶心呕吐的发生率低于对照组(P<0.05).结论 益气养阴清热解毒汤可提升MPE患者免疫功能,减轻炎症反应,改善肺功能,以及降低中医证候积分和肺纤维化发生率.
Objective To investigate the effects of the Yiqi Yangyin Qingre Jiedu decoction combined with cisplatin perfusion on the immune function,inflammatory response and pulmonary fibrosis in the treatment of patients with malignant pleural effusion(MPE)of lung cancer with Qi and Yin deficiency.Methods A total of 80 MPE patients admitted to the hospital from January 2020 to February 2025 were selected as the research subjects.They were divided into the control group(receiving thoracic puncture drainage followed by cisplatin perfusion treatment)and the observation group(receiving Yiqi Yangyin Qingre Jiedu decoction treatment on the basis of the control group),with 40 cases in each group.The pulmonary fibrosis and adverse reactions and immune function indicators[CD3+,CD4+,CD8+T cell proportions and CD4+/CD8+ratio],serum inflamma-tory factors[C-reactive protein(CRP),interleukin-6(IL-6),serum tumor necrosis factor-α(TNF-α)],pulmo-nary function indicators[forced vital capacity(FVC),first-second forced vital capacity(FEV1),maximum re-spiratory flow rate(PEF)],Traditional Chinese Medicine(TCM)Symptom scores were compared between the two groups before and after treatment.Results After 3 weeks of treatment,the CD3+T cell,CD4+T cell proportions and CD4+/CD8+ratio in the two groups were higher than those before treatment,and the CD3+T cells,CD4+T cell proportions and CD4+/CD8+ratio in the observation group were higher than those in the control group,with statistically significant differences(P<0.05).After 3 weeks of treatment,the serum CRP,IL-6,TNF-α levels and CD8+T cell proportion in the two groups were lower than those before treat-ment,and the serum CRP,IL-6,TNF-α levels and CD8+T cell proportion in the observation group were lower than those in the control group,with statistically significant differences(P<0.05).After 3 weeks of treat-ment,the FVC,FEV1 and PEF in the two groups were higher than those before treatment,and the FVC,FEV1 and PEF in the observation group were higher than those in the control group,with statistically significant differences(P<0.05).After 3 weeks of treatment,the scores of cough with little phlegm,low-pitched cough,fatigue,hot flushes and night sweats,dizziness and blurred vision and pale complexion,as well as the total scores in the two groups were lower than those before treatment,and the scores of cough with little phlegm,low-pitched cough,fatigue,hot flushes and night sweats,dizziness and blurred vision,and pale complexion,as well as the total scores in the observation group were lower than those in the control group,with statistically significant differences(P<0.05).After 3 weeks of treatment,the differences in pulmonary fibrosis grades be-tween the two groups were statistically significant(P<0.05).During the treatment period,the incidence of bone marrow suppression and nausea and vomiting in the observation group was lower than that in the control group(P<0.05).Conclusion The Yiqi Yangyin Qingre Jiedu decoction can improve the immune function of MPE patients,reduce inflammatory response,improve pulmonary function and reduce TCM Syndrome scores and the incidence of pulmonary fibrosis.
黄婷婷;潘静洁;刘堂营
广州市胸科医院:中医内科,广东 广州 510095广州市胸科医院:中医科,广东 广州 510095广州市胸科医院:中医科,广东 广州 510095
医药卫生
益气养阴清热解毒汤肺癌恶性胸腔积液免疫功能肺纤维化
Yiqi Yangyin Qingre Jiedu decoctionlung cancermalignant pleural effusionimmune functionpulmonary fibrosis
《检验医学与临床》 2026 (9)
1190-1195,1201,7
广东省中医药局科研课题(202205110840231140).
评论